Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 70/100

Failure Rate

33.3%

1 terminated/withdrawn out of 3 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

33%

1 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(33.3%)
Phase 4
1(33.3%)
Phase 1
1(33.3%)
3Total
Phase 2(1)
Phase 4(1)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT00181181Phase 4Terminated

The Effect of Statin Use on Vascular Function in Hypertensive Subjects

Role: collaborator

NCT00700518Phase 1Completed

Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon

Role: lead

NCT00641953Phase 2Completed

IMX-150 Cream for Diabetic Neuropathy

Role: lead

All 3 trials loaded